Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts
Background: Lymphatic filariasis (LF) is endemic in 83 countries and territories, with more than a billion people at risk of infection. In view with the global elimination, mass drug administration (MDA) with single dose of diethylcarbamazine and albendazole tablets was carried out for the eligible...
Main Author: | Prakash Kurubarahalli Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Community Medicine |
Subjects: | |
Online Access: | http://www.ijcm.org.in/article.asp?issn=0970-0218;year=2012;volume=37;issue=2;spage=101;epage=106;aulast=Patel |
Similar Items
-
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021-03-01) -
Lymphatic Filariasis Presenting as a Swelling over the Upper Arm: A Case Report
by: Sharma GM, et al.
Published: (2018-03-01) -
Coverage evaluation of mass drug administration for lymphatic filariasis in Bidar district, Karnataka, India
by: H S Ravish, et al.
Published: (2015-01-01) -
Endpoints for Lymphatic Filariasis Programs
by: Caroline A. Grady, et al.
Published: (2007-04-01) -
Coverage Validation Survey for Lymphatic Filariasis Treatment in Itang Special District of Gambella Regional State of Ethiopia: A Cross-Sectional Study
by: Teshome A, et al.
Published: (2021-04-01)